Therapeutic effect of transurethral plasmakinetic enucleation of the prostate with anterior lobe of the prostate reserved for benign prostatic hyperplasia

Objective To observe and evaluate the clinical effect of transurethral plasmakinetic enucleation of the prostate with anterior lobe of the prostate reserved (PKEP) in the treatment of benign prostatic hyperplasia (BPH). Methods Seventy-five patients with benign prostatic hyperplasia were divided into two groups according to different surgical methods. 35 patients in the control group were treated with PKRP; 40 patients in the observation group were treated with PKEP. And the clinical effects of the two groups were compared. Results The operative time of the observation group [(45.98±7.13) min] was significantly shorter than that of the control group [(54.86±7.08) min] (t=4.962 5, P 0.05); IPSS, RUV, Qmax, and QOL score were significantly improved after treatment (P<0.05), the Qmax of the observation group was significantly higher than that of the control group (t=3.917 5, P<0.05). Conclusions Transurethral plasmakinetic enucleation of the prostate with anterior lobe of the prostate reserved (PKEP) is effective in the treatment of benign prostatic hyperplasia (BPH), with less trauma, shorter operative time, less bleeding, lower complication rate, safety and reliability, and easier recovery. Key words: Benign prostatic hyperplasia (BPH); Preserving anterior lobe; Transurethral plasmakinetic enucleation of the prostate(PKEP); Transurethral plasmakinetic resection of the prostate (PKRP)